MANNKIND CORP·4

Aug 4, 6:39 PM ET

Kendall David M 4

4 · MANNKIND CORP · Filed Aug 4, 2020

Insider Transaction Report

Form 4
Period: 2020-07-31
Kendall David M
Chief Medical Officer
Transactions
  • Purchase

    Common Stock, $0.01 Par Value

    2020-07-31$1.25/sh+4,041$5,05141,059 total
Footnotes (1)
  • [F1]The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION